化合物Raphin1 acetate T8519
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 2242616-04-0 | ¥987.00 | 询底价 |
50 mg | 2242616-04-0 | ¥3,180.00 | 询底价 |
1 mg | 2242616-04-0 | ¥283.00 | 询底价 |
1 mL | 2242616-04-0 | ¥628.00 | 询底价 |
5 mg | 2242616-04-0 | ¥652.00 | 询底价 |
100 mg | 2242616-04-0 | ¥4,570.00 | 询底价 |
25 mg | 2242616-04-0 | ¥1,980.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Raphin1 acetate
描述: Raphin1 acetate 是具有口服活性的、可透过血脑屏障的、选择性调节性磷酸酶PPP1R15B 抑制剂。它与 R15B-PP1c 全磷酸酶强烈结合 (Kd=33 nM),与 R15A-PP1c 相比,结合 R15B-PP1c 约为其 30 倍的选择性。它可减少蛋白质错误折叠疾病的小鼠模型中的生物和分子缺陷。
体外活性: Raphin1, a selective inhibitor of R15B.?In cells, Raphin1 caused a rapid and transient accumulation of its phosphorylated substrate, resulting in a transient attenuation of protein synthesis.?In vitro, Raphin1 inhibits the recombinant R15B-PP1c holoenzyme, but not the closely related R15A-PP1c, by interfering with substrate recruitment.
体内活性: Raphin1 was orally bioavailable, crossed the blood-brain barrier, and demonstrated efficacy in a mouse model of Huntington's disease.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 40 mg/mL (137.4 mM)
关键字: Raphin1 | Phosphatase | Raphin-1 acetate | Raphin-1 | Raphin1 acetate | Raphin 1 | Raphin1 Acetate | inhibit | Inhibitor
相关产品: Stearic acid | BN82002 | AS1949490 | Anticancer agent 144 | PTPσ Inhibitor, ISP | KY-226 | LUPENONE | Abyssinone V | MLS000544460 | Sodium etidronate
相关库: Glycometabolism Compound Library | Anti-Metabolism Disease Compound Library | Bioactive Compounds Library Max | Phosphatase Inhibitor Library | CNS-Penetrant Compound Library | Inhibitor Library | Metabolism Compound Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物Raphin1 acetate T8519信息由TargetMol中国为您提供,如您想了解更多关于化合物Raphin1 acetate T8519报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途